A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma
| Image |  |
|---|---|
| Description | scientific article published on April 27, 2012 |
| Author/s |
author: Mark Agulnik |
| Publication date | April 27, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://link.springer.com/content/pdf/10.1007/s10637-012-9819-5.pdf |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |